|
Aurobindo Pharma Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
87793.97 Cr.
|
P/BV
|
2.44
|
Book Value (Rs.)
|
618.98
|
|
52 Week High/Low (Rs.)
|
1526/1016
|
FV/ML
|
1/1
|
P/E(X)
|
25.19
|
|
Bookclosure
|
17/04/2026
|
EPS (Rs.)
|
60.02
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 31378.13 | 28704.50 | 24617.13 | 23366.55 | 24557.94 |
| Other Operating Revenues | 345.60 | 297.37 | 238.25 | 88.94 | 216.68 |
| Total Operating Revenues | 31723.73 | 29001.87 | 24855.38 | 23455.49 | 24774.62 |
| | | | | | |
| Other Income | 621.85 | 557.38 | 290.59 | 320.35 | 380.85 |
| Total Revenue | 32345.58 | 29559.25 | 25145.97 | 23775.84 | 25155.47 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 10736.76 | 10776.14 | 9652.51 | 7371.83 | 8317.26 |
| Purchase Of Stock-In Trade | 2887.11 | 2772.93 | 2050.43 | 1951.77 | 2315.42 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -597.63 | -946.17 | -409.68 | 816.68 | -730.21 |
| Employee Benefit Expenses | 4475.62 | 3922.94 | 3522.25 | 3450.92 | 3535.02 |
| Finance Costs | 457.24 | 289.71 | 140.48 | 48.64 | 74.49 |
| Depreciation And Amortisation Expenses | 1649.42 | 1521.66 | 1244.58 | 1126.52 | 1055.39 |
| Other Expenses | 7639.08 | 6633.03 | 6321.23 | 5477.52 | 6003.73 |
| Total Expenses | 27247.60 | 24970.24 | 22521.80 | 20243.88 | 20571.10 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 5097.98 | 4589.01 | 2624.17 | 3531.96 | 4584.37 |
| | | | | | |
| Exceptional Items | 0.00 | -191.86 | 0.00 | -127.97 | 2814.58 |
| Profit/Loss Before Tax | 5097.98 | 4397.15 | 2624.17 | 3403.99 | 7398.95 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 1699.98 | 1777.54 | 1071.48 | 662.82 | 2321.82 |
| Deferred Tax | -117.26 | -566.52 | -386.63 | 62.81 | -312.05 |
| Total Tax Expenses | 1582.72 | 1211.02 | 684.85 | 725.63 | 2009.77 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 3515.26 | 3186.13 | 1939.32 | 2678.36 | 5389.18 |
| | | | | | |
| Profit/Loss From Continuing Operations | 3515.26 | 3186.13 | 1939.32 | 2678.36 | 5389.18 |
| | | | | | |
| Profit/Loss For The Period | 3515.26 | 3186.13 | 1939.32 | 2678.36 | 5389.18 |
| | | | | | |
| Minority Interest | 2.31 | 4.00 | -0.15 | 1.04 | 1.02 |
| Share Of Profit/Loss Of Associates | -31.69 | -17.16 | -11.67 | -31.25 | -55.36 |
| Consolidated Profit/Loss After MI And Associates | 3485.88 | 3172.97 | 1927.50 | 2648.15 | 5334.84 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 59.81 | 54.16 | 32.90 | 45.19 | 91.05 |
| Diluted EPS (Rs.) | 59.81 | 54.16 | 32.90 | 45.19 | 91.05 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 0.00 | 0.00 | 439.45 | 263.67 | 234.38 |
